Clinical trial
A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil…
NCT00483028 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00483028 |
|---|---|
| Title | A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI |
| Official title | A Randomized Double-Blind, Parallel, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil (5 mg QD for 6 Weeks) After Single Dose and Steady State Therapy (2 Weeks and 6 Weeks) in Subjects With Mild Cognitive Impairment |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | donezepil (Aricept) |
| Enrollment | 38 |
| Start date | Jun 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | Jun 6, 2007 |
| Last update posted | Feb 5, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: